Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.

计划入组 278 人 · 首次发布于 2006 年 3 月 2 日

R5 Integrase Study in HIV-1 Naive Patients

计划入组 7 人 · 首次发布于 2010 年 9 月 17 日

Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1

计划入组 10 人 · 首次发布于 2008 年 12 月 12 日

HIV-1 integrase inhibitors(CellVir)

HIV-1 integrase inhibitors (Merck & Co)

HIV-1 integrase inhibitors(GlaxoSmithKline LLC)

Worcester HIV Vaccine

United States

NHI-1

United States

HIV VACCINE TRIALS NETWORK

United States

ST Pharm's Pirmitegravir Shows First Clinical Proof of Concept for Novel HIV Drug Class

Code Pharma's GAMMORA Shows Promise in Targeting and Eliminating HIV-Infected Cells

Lupin Receives Tentative FDA Approval for Generic Raltegravir Tablets